Abbott, the broad-based health care company, will invest $230m (Eur160m) to build a state-of-the-art nutrition manufacturing facility in Jiaxing, China. The facility represents Abbott’s largest investment in China to date
Abbott, the broad-based health care company, will invest $230m (Eur160m) to build a state-of-the-art nutrition manufacturing facility in Jiaxing, China. The facility represents Abbott’s largest investment in China to date